21 CFR Part 5 - ORGANIZATION

{'United States Code': [{'Title': '21', 'Section': '301', 'headtext': ' Short title', 'cleanpath': '/uscode/text/21/301'}, {'Title': '21', 'Section': '321', 'headtext': ' Definitions; generally', 'cleanpath': '/uscode/text/21/321'}, {'Title': '21', 'Section': '321a', 'headtext': ' “Butter” defined', 'cleanpath': '/uscode/text/21/321a'}, {'Title': '21', 'Section': '321b', 'headtext': ' “Package” defined', 'cleanpath': '/uscode/text/21/321b'}, {'Title': '21', 'Section': '321c', 'headtext': ' Nonfat dry milk; “milk” defined', 'cleanpath': '/uscode/text/21/321c'}, {'Title': '21', 'Section': '321d', 'headtext': ' Market names for catfish and ginseng', 'cleanpath': '/uscode/text/21/321d'}, {'Title': '21', 'Section': '331', 'headtext': ' Prohibited acts', 'cleanpath': '/uscode/text/21/331'}, {'Title': '21', 'Section': '332', 'headtext': ' Injunction proceedings', 'cleanpath': '/uscode/text/21/332'}, {'Title': '21', 'Section': '333', 'headtext': ' Penalties', 'cleanpath': '/uscode/text/21/333'}, {'Title': '21', 'Section': '333a', 'headtext': ' Repealed. Pub. L. 101–647, title XIX, §\u202f1905, Nov. 29, 1990, 104 Stat. 4853', 'cleanpath': '/uscode/text/21/333a'}, {'Title': '21', 'Section': '334', 'headtext': ' Seizure', 'cleanpath': '/uscode/text/21/334'}, {'Title': '21', 'Section': '335', 'headtext': ' Hearing before report of criminal violation', 'cleanpath': '/uscode/text/21/335'}, {'Title': '21', 'Section': '335a', 'headtext': ' Debarment, temporary denial of approval, and suspension', 'cleanpath': '/uscode/text/21/335a'}, {'Title': '21', 'Section': '335b', 'headtext': ' Civil penalties', 'cleanpath': '/uscode/text/21/335b'}, {'Title': '21', 'Section': '335c', 'headtext': ' Authority to withdraw approval of abbreviated drug applications', 'cleanpath': '/uscode/text/21/335c'}, {'Title': '21', 'Section': '336', 'headtext': ' Report of minor violations', 'cleanpath': '/uscode/text/21/336'}, {'Title': '21', 'Section': '337', 'headtext': ' Proceedings in name of United States; provision as to subpoenas', 'cleanpath': '/uscode/text/21/337'}, {'Title': '21', 'Section': '341', 'headtext': ' Definitions and standards for food', 'cleanpath': '/uscode/text/21/341'}, {'Title': '21', 'Section': '342', 'headtext': ' Adulterated food', 'cleanpath': '/uscode/text/21/342'}, {'Title': '21', 'Section': '343', 'headtext': ' Misbranded food', 'cleanpath': '/uscode/text/21/343'}, {'Title': '21', 'Section': '343-1', 'headtext': ' National uniform nutrition labeling', 'cleanpath': '/uscode/text/21/343-1'}, {'Title': '21', 'Section': '343-2', 'headtext': ' Dietary supplement labeling exemptions', 'cleanpath': '/uscode/text/21/343-2'}, {'Title': '21', 'Section': '343-3', 'headtext': ' Disclosure', 'cleanpath': '/uscode/text/21/343-3'}, {'Title': '21', 'Section': '343a', 'headtext': ' Repealed. Pub. L. 106–554, §\u202f1(a)(1) [title V, §\u202f517], Dec. 21, 2000, 114 Stat. 2763, 2763A–73', 'cleanpath': '/uscode/text/21/343a'}, {'Title': '21', 'Section': '344', 'headtext': ' Emergency permit control', 'cleanpath': '/uscode/text/21/344'}, {'Title': '21', 'Section': '345', 'headtext': ' Regulations making exemptions', 'cleanpath': '/uscode/text/21/345'}, {'Title': '21', 'Section': '346', 'headtext': ' Tolerances for poisonous or deleterious substances in food; regulations', 'cleanpath': '/uscode/text/21/346'}, {'Title': '21', 'Section': '346a', 'headtext': ' Tolerances and exemptions for pesticide chemical residues', 'cleanpath': '/uscode/text/21/346a'}, {'Title': '21', 'Section': '346b', 'headtext': ' Authorization of appropriations', 'cleanpath': '/uscode/text/21/346b'}, {'Title': '21', 'Section': '347', 'headtext': ' Intrastate sales of colored oleomargarine', 'cleanpath': '/uscode/text/21/347'}, {'Title': '21', 'Section': '347a', 'headtext': ' Congressional declaration of policy regarding oleomargarine sales', 'cleanpath': '/uscode/text/21/347a'}, {'Title': '21', 'Section': '347b', 'headtext': ' Contravention of State laws', 'cleanpath': '/uscode/text/21/347b'}, {'Title': '21', 'Section': '348', 'headtext': ' Food additives', 'cleanpath': '/uscode/text/21/348'}, {'Title': '21', 'Section': '349', 'headtext': ' Bottled drinking water standards; publication in Federal Register', 'cleanpath': '/uscode/text/21/349'}, {'Title': '21', 'Section': '350', 'headtext': ' Vitamins and minerals', 'cleanpath': '/uscode/text/21/350'}, {'Title': '21', 'Section': '350a', 'headtext': ' Infant formulas', 'cleanpath': '/uscode/text/21/350a'}, {'Title': '21', 'Section': '350b', 'headtext': ' New dietary ingredients', 'cleanpath': '/uscode/text/21/350b'}, {'Title': '21', 'Section': '350c', 'headtext': ' Maintenance and inspection of records', 'cleanpath': '/uscode/text/21/350c'}, {'Title': '21', 'Section': '350d', 'headtext': ' Registration of food facilities', 'cleanpath': '/uscode/text/21/350d'}, {'Title': '21', 'Section': '350e', 'headtext': ' Sanitary transportation practices', 'cleanpath': '/uscode/text/21/350e'}, {'Title': '21', 'Section': '350f', 'headtext': ' Reportable food registry', 'cleanpath': '/uscode/text/21/350f'}, {'Title': '21', 'Section': '350g', 'headtext': ' Hazard analysis and risk-based preventive controls', 'cleanpath': '/uscode/text/21/350g'}, {'Title': '21', 'Section': '350h', 'headtext': ' Standards for produce safety', 'cleanpath': '/uscode/text/21/350h'}, {'Title': '21', 'Section': '350i', 'headtext': ' Protection against intentional adulteration', 'cleanpath': '/uscode/text/21/350i'}, {'Title': '21', 'Section': '350j', 'headtext': ' Targeting of inspection resources for domestic facilities, foreign facilities, and ports of entry; annual report', 'cleanpath': '/uscode/text/21/350j'}, {'Title': '21', 'Section': '350k', 'headtext': ' Laboratory accreditation for analyses of foods', 'cleanpath': '/uscode/text/21/350k'}, {'Title': '21', 'Section': '350l', 'headtext': ' Mandatory recall authority', 'cleanpath': '/uscode/text/21/350l'}, {'Title': '21', 'Section': '350l-1', 'headtext': ' Annual report to Congress', 'cleanpath': '/uscode/text/21/350l-1'}, {'Title': '21', 'Section': '351', 'headtext': ' Adulterated drugs and devices', 'cleanpath': '/uscode/text/21/351'}, {'Title': '21', 'Section': '352', 'headtext': ' Misbranded drugs and devices', 'cleanpath': '/uscode/text/21/352'}, {'Title': '21', 'Section': '353', 'headtext': ' Exemptions and consideration for certain drugs, devices, and biological products', 'cleanpath': '/uscode/text/21/353'}, {'Title': '21', 'Section': '353a', 'headtext': ' Pharmacy compounding', 'cleanpath': '/uscode/text/21/353a'}, {'Title': '21', 'Section': '353b', 'headtext': ' Outsourcing facilities', 'cleanpath': '/uscode/text/21/353b'}, {'Title': '21', 'Section': '354', 'headtext': ' Veterinary feed directive drugs', 'cleanpath': '/uscode/text/21/354'}, {'Title': '21', 'Section': '355', 'headtext': ' New drugs', 'cleanpath': '/uscode/text/21/355'}, {'Title': '21', 'Section': '355-1', 'headtext': ' Risk evaluation and mitigation strategies', 'cleanpath': '/uscode/text/21/355-1'}, {'Title': '21', 'Section': '355a', 'headtext': ' Pediatric studies of drugs', 'cleanpath': '/uscode/text/21/355a'}, {'Title': '21', 'Section': '355b', 'headtext': ' Adverse-event reporting', 'cleanpath': '/uscode/text/21/355b'}, {'Title': '21', 'Section': '355c', 'headtext': ' Research into pediatric uses for drugs and biological products', 'cleanpath': '/uscode/text/21/355c'}, {'Title': '21', 'Section': '355d', 'headtext': ' Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers', 'cleanpath': '/uscode/text/21/355d'}, {'Title': '21', 'Section': '355e', 'headtext': ' Pharmaceutical security', 'cleanpath': '/uscode/text/21/355e'}, {'Title': '21', 'Section': '356', 'headtext': ' Expedited approval of drugs for serious or life-threatening diseases or conditions', 'cleanpath': '/uscode/text/21/356'}, {'Title': '21', 'Section': '356-1', 'headtext': ' Accelerated approval of priority countermeasures', 'cleanpath': '/uscode/text/21/356-1'}, {'Title': '21', 'Section': '356a', 'headtext': ' Manufacturing changes', 'cleanpath': '/uscode/text/21/356a'}, {'Title': '21', 'Section': '356b', 'headtext': ' Reports of postmarketing studies', 'cleanpath': '/uscode/text/21/356b'}, {'Title': '21', 'Section': '356c', 'headtext': ' Discontinuance or interruption in the production of life-saving drugs', 'cleanpath': '/uscode/text/21/356c'}, {'Title': '21', 'Section': '357', 'headtext': ' Qualification of drug development tools', 'cleanpath': '/uscode/text/21/357'}, {'Title': '21', 'Section': '358', 'headtext': ' Authority to designate official names', 'cleanpath': '/uscode/text/21/358'}, {'Title': '21', 'Section': '359', 'headtext': ' Nonapplicability of subchapter to cosmetics', 'cleanpath': '/uscode/text/21/359'}, {'Title': '21', 'Section': '360', 'headtext': ' Registration of producers of drugs or devices', 'cleanpath': '/uscode/text/21/360'}, {'Title': '21', 'Section': '360a', 'headtext': ' Clinical trial guidance for antibiotic drugs', 'cleanpath': '/uscode/text/21/360a'}, {'Title': '21', 'Section': '360b', 'headtext': ' New animal drugs', 'cleanpath': '/uscode/text/21/360b'}, {'Title': '21', 'Section': '360c', 'headtext': ' Classification of devices intended for human use', 'cleanpath': '/uscode/text/21/360c'}, {'Title': '21', 'Section': '360d', 'headtext': ' Performance standards', 'cleanpath': '/uscode/text/21/360d'}, {'Title': '21', 'Section': '360e', 'headtext': ' Premarket approval', 'cleanpath': '/uscode/text/21/360e'}, {'Title': '21', 'Section': '360e-1', 'headtext': ' Pediatric uses of devices', 'cleanpath': '/uscode/text/21/360e-1'}, {'Title': '21', 'Section': '360f', 'headtext': ' Banned devices', 'cleanpath': '/uscode/text/21/360f'}, {'Title': '21', 'Section': '360g', 'headtext': ' Judicial review', 'cleanpath': '/uscode/text/21/360g'}, {'Title': '21', 'Section': '360h', 'headtext': ' Notification and other remedies', 'cleanpath': '/uscode/text/21/360h'}, {'Title': '21', 'Section': '360i', 'headtext': ' Records and reports on devices', 'cleanpath': '/uscode/text/21/360i'}, {'Title': '21', 'Section': '360j', 'headtext': ' General provisions respecting control of devices intended for human use', 'cleanpath': '/uscode/text/21/360j'}, {'Title': '21', 'Section': '360k', 'headtext': ' State and local requirements respecting devices', 'cleanpath': '/uscode/text/21/360k'}, {'Title': '21', 'Section': '360l', 'headtext': ' Postmarket surveillance', 'cleanpath': '/uscode/text/21/360l'}, {'Title': '21', 'Section': '360m', 'headtext': ' Accredited persons', 'cleanpath': '/uscode/text/21/360m'}, {'Title': '21', 'Section': '360n', 'headtext': ' Priority review to encourage treatments for tropical diseases', 'cleanpath': '/uscode/text/21/360n'}, {'Title': '21', 'Section': '360aa', 'headtext': ' Recommendations for investigations of drugs for rare diseases or conditions', 'cleanpath': '/uscode/text/21/360aa'}, {'Title': '21', 'Section': '360bb', 'headtext': ' Designation of drugs for rare diseases or conditions', 'cleanpath': '/uscode/text/21/360bb'}, {'Title': '21', 'Section': '360cc', 'headtext': ' Protection for drugs for rare diseases or conditions', 'cleanpath': '/uscode/text/21/360cc'}, {'Title': '21', 'Section': '360dd', 'headtext': ' Open protocols for investigations of drugs for rare diseases or conditions', 'cleanpath': '/uscode/text/21/360dd'}, {'Title': '21', 'Section': '360ee', 'headtext': ' Grants and contracts for development of drugs for rare diseases and conditions', 'cleanpath': '/uscode/text/21/360ee'}, {'Title': '21', 'Section': '360hh', 'headtext': ' Definitions', 'cleanpath': '/uscode/text/21/360hh'}, {'Title': '21', 'Section': '360ii', 'headtext': ' Program of control', 'cleanpath': '/uscode/text/21/360ii'}, {'Title': '21', 'Section': '360jj', 'headtext': ' Studies by Secretary', 'cleanpath': '/uscode/text/21/360jj'}, {'Title': '21', 'Section': '360kk', 'headtext': ' Performance standards for electronic products', 'cleanpath': '/uscode/text/21/360kk'}, {'Title': '21', 'Section': '360ll', 'headtext': ' Notification of defects in and repair or replacement of electronic products', 'cleanpath': '/uscode/text/21/360ll'}, {'Title': '21', 'Section': '360mm', 'headtext': ' Imports', 'cleanpath': '/uscode/text/21/360mm'}, {'Title': '21', 'Section': '360nn', 'headtext': ' Inspection, records, and reports', 'cleanpath': '/uscode/text/21/360nn'}, {'Title': '21', 'Section': '360oo', 'headtext': ' Prohibited acts', 'cleanpath': '/uscode/text/21/360oo'}, {'Title': '21', 'Section': '360pp', 'headtext': ' Enforcement', 'cleanpath': '/uscode/text/21/360pp'}, {'Title': '21', 'Section': '360qq', 'headtext': ' Repealed. Pub. L. 105–362, title VI, §\u202f601(a)(2)(A), Nov. 10, 1998, 112 Stat. 3285', 'cleanpath': '/uscode/text/21/360qq'}, {'Title': '21', 'Section': '360rr', 'headtext': ' Federal-State cooperation', 'cleanpath': '/uscode/text/21/360rr'}, {'Title': '21', 'Section': '360ss', 'headtext': ' State standards', 'cleanpath': '/uscode/text/21/360ss'}, {'Title': '21', 'Section': '360aaa', 'headtext': ' Omitted', 'cleanpath': '/uscode/text/21/360aaa'}, {'Title': '21', 'Section': '360bbb', 'headtext': ' Expanded access to unapproved therapies and diagnostics', 'cleanpath': '/uscode/text/21/360bbb'}, {'Title': '21', 'Section': '360bbb-1', 'headtext': ' Dispute resolution', 'cleanpath': '/uscode/text/21/360bbb-1'}, {'Title': '21', 'Section': '360bbb-2', 'headtext': ' Classification of products', 'cleanpath': '/uscode/text/21/360bbb-2'}, {'Title': '21', 'Section': '360bbb-3', 'headtext': ' Authorization for medical products for use in emergencies', 'cleanpath': '/uscode/text/21/360bbb-3'}, {'Title': '21', 'Section': '360bbb-4', 'headtext': ' Countermeasure development, review, and technical assistance', 'cleanpath': '/uscode/text/21/360bbb-4'}, {'Title': '21', 'Section': '360bbb-5', 'headtext': ' Critical Path Public-Private Partnerships', 'cleanpath': '/uscode/text/21/360bbb-5'}, {'Title': '21', 'Section': '360bbb-6', 'headtext': ' Risk communication', 'cleanpath': '/uscode/text/21/360bbb-6'}, {'Title': '21', 'Section': '360ccc', 'headtext': ' Conditional approval of new animal drugs for minor use and minor species and certain new animal drugs', 'cleanpath': '/uscode/text/21/360ccc'}, {'Title': '21', 'Section': '360ccc-1', 'headtext': ' Index of legally marketed unapproved new animal drugs for minor species', 'cleanpath': '/uscode/text/21/360ccc-1'}, {'Title': '21', 'Section': '360ccc-2', 'headtext': ' Designated new animal drugs for minor use or minor species', 'cleanpath': '/uscode/text/21/360ccc-2'}, {'Title': '21', 'Section': '361', 'headtext': ' Adulterated cosmetics', 'cleanpath': '/uscode/text/21/361'}, {'Title': '21', 'Section': '362', 'headtext': ' Misbranded cosmetics', 'cleanpath': '/uscode/text/21/362'}, {'Title': '21', 'Section': '363', 'headtext': ' Regulations making exemptions', 'cleanpath': '/uscode/text/21/363'}, {'Title': '21', 'Section': '364', 'headtext': ' Repealed. Pub. L. 86–618, title I, §\u202f103(a)(3), July 12, 1960, 74 Stat. 398', 'cleanpath': '/uscode/text/21/364'}, {'Title': '21', 'Section': '371', 'headtext': ' Regulations and hearings', 'cleanpath': '/uscode/text/21/371'}, {'Title': '21', 'Section': '372', 'headtext': ' Examinations and investigations', 'cleanpath': '/uscode/text/21/372'}, {'Title': '21', 'Section': '372a', 'headtext': ' Transferred', 'cleanpath': '/uscode/text/21/372a'}, {'Title': '21', 'Section': '373', 'headtext': ' Records', 'cleanpath': '/uscode/text/21/373'}, {'Title': '21', 'Section': '374', 'headtext': ' Inspection', 'cleanpath': '/uscode/text/21/374'}, {'Title': '21', 'Section': '374a', 'headtext': ' Inspections relating to food allergens', 'cleanpath': '/uscode/text/21/374a'}, {'Title': '21', 'Section': '375', 'headtext': ' Publicity', 'cleanpath': '/uscode/text/21/375'}, {'Title': '21', 'Section': '376', 'headtext': ' Examination of sea food on request of packer; marking food with results; fees; penalties', 'cleanpath': '/uscode/text/21/376'}, {'Title': '21', 'Section': '377', 'headtext': ' Revision of United States Pharmacopoeia; development of analysis and mechanical and physical tests', 'cleanpath': '/uscode/text/21/377'}, {'Title': '21', 'Section': '378', 'headtext': ' Advertising of foods', 'cleanpath': '/uscode/text/21/378'}, {'Title': '21', 'Section': '379', 'headtext': ' Confidential information', 'cleanpath': '/uscode/text/21/379'}, {'Title': '21', 'Section': '379a', 'headtext': ' Presumption of existence of jurisdiction', 'cleanpath': '/uscode/text/21/379a'}, {'Title': '21', 'Section': '379b', 'headtext': ' Consolidated administrative and laboratory facility', 'cleanpath': '/uscode/text/21/379b'}, {'Title': '21', 'Section': '379c', 'headtext': ' Transferred', 'cleanpath': '/uscode/text/21/379c'}, {'Title': '21', 'Section': '379d', 'headtext': ' Automation of Food and Drug Administration', 'cleanpath': '/uscode/text/21/379d'}, {'Title': '21', 'Section': '379d-1', 'headtext': ' Conflicts of interest', 'cleanpath': '/uscode/text/21/379d-1'}, {'Title': '21', 'Section': '379d-2', 'headtext': ' Policy on the review and clearance of scientific articles published by FDA employees', 'cleanpath': '/uscode/text/21/379d-2'}, {'Title': '21', 'Section': '379e', 'headtext': ' Listing and certification of color additives for foods, drugs, devices, and cosmetics', 'cleanpath': '/uscode/text/21/379e'}, {'Title': '21', 'Section': '379f', 'headtext': ' Recovery and retention of fees for freedom of information requests', 'cleanpath': '/uscode/text/21/379f'}, {'Title': '21', 'Section': '379g', 'headtext': ' Definitions', 'cleanpath': '/uscode/text/21/379g'}, {'Title': '21', 'Section': '379h', 'headtext': ' Authority to assess and use drug fees', 'cleanpath': '/uscode/text/21/379h'}, {'Title': '21', 'Section': '379h-1', 'headtext': ' Fees relating to advisory review of prescription-drug television advertising', 'cleanpath': '/uscode/text/21/379h-1'}, {'Title': '21', 'Section': '379h-2', 'headtext': ' Reauthorization; reporting requirements', 'cleanpath': '/uscode/text/21/379h-2'}, {'Title': '21', 'Section': '379i', 'headtext': ' Definitions', 'cleanpath': '/uscode/text/21/379i'}, {'Title': '21', 'Section': '379j', 'headtext': ' Authority to assess and use device fees', 'cleanpath': '/uscode/text/21/379j'}, {'Title': '21', 'Section': '379j-1', 'headtext': ' Reauthorization; reporting requirements', 'cleanpath': '/uscode/text/21/379j-1'}, {'Title': '21', 'Section': '379j-11', 'headtext': ' Definitions', 'cleanpath': '/uscode/text/21/379j-11'}, {'Title': '21', 'Section': '379j-12', 'headtext': ' Authority to assess and use animal drug fees', 'cleanpath': '/uscode/text/21/379j-12'}, {'Title': '21', 'Section': '379j-13', 'headtext': ' Reauthorization; reporting requirements', 'cleanpath': '/uscode/text/21/379j-13'}, {'Title': '21', 'Section': '379j-21', 'headtext': ' Authority to assess and use generic new animal drug fees', 'cleanpath': '/uscode/text/21/379j-21'}, {'Title': '21', 'Section': '379j-22', 'headtext': ' Reauthorization; reporting requirements', 'cleanpath': '/uscode/text/21/379j-22'}, {'Title': '21', 'Section': '379j-31', 'headtext': ' Authority to collect and use fees', 'cleanpath': '/uscode/text/21/379j-31'}, {'Title': '21', 'Section': '379k', 'headtext': ' Information system', 'cleanpath': '/uscode/text/21/379k'}, {'Title': '21', 'Section': '379l', 'headtext': ' Education', 'cleanpath': '/uscode/text/21/379l'}, {'Title': '21', 'Section': '379o', 'headtext': ' Environmental impact', 'cleanpath': '/uscode/text/21/379o'}, {'Title': '21', 'Section': '379r', 'headtext': ' National uniformity for nonprescription drugs', 'cleanpath': '/uscode/text/21/379r'}, {'Title': '21', 'Section': '379s', 'headtext': ' Preemption for labeling or packaging of cosmetics', 'cleanpath': '/uscode/text/21/379s'}, {'Title': '21', 'Section': '379v', 'headtext': ' Safety report disclaimers', 'cleanpath': '/uscode/text/21/379v'}, {'Title': '21', 'Section': '379aa', 'headtext': ' Serious adverse event reporting for nonprescription drugs', 'cleanpath': '/uscode/text/21/379aa'}, {'Title': '21', 'Section': '379aa-1', 'headtext': ' Serious adverse event reporting for dietary supplements', 'cleanpath': '/uscode/text/21/379aa-1'}, {'Title': '21', 'Section': '379dd', 'headtext': ' Establishment and functions of the Foundation', 'cleanpath': '/uscode/text/21/379dd'}, {'Title': '21', 'Section': '379dd-1', 'headtext': ' Location of Foundation', 'cleanpath': '/uscode/text/21/379dd-1'}, {'Title': '21', 'Section': '379dd-2', 'headtext': ' Activities of the Food and Drug Administration', 'cleanpath': '/uscode/text/21/379dd-2'}, {'Title': '21', 'Section': '381', 'headtext': ' Imports and exports', 'cleanpath': '/uscode/text/21/381'}, {'Title': '21', 'Section': '382', 'headtext': ' Exports of certain unapproved products', 'cleanpath': '/uscode/text/21/382'}, {'Title': '21', 'Section': '383', 'headtext': ' Office of International Relations', 'cleanpath': '/uscode/text/21/383'}, {'Title': '21', 'Section': '384', 'headtext': ' Importation of prescription drugs', 'cleanpath': '/uscode/text/21/384'}, {'Title': '21', 'Section': '384a', 'headtext': ' Foreign supplier verification program', 'cleanpath': '/uscode/text/21/384a'}, {'Title': '21', 'Section': '384b', 'headtext': ' Voluntary qualified importer program', 'cleanpath': '/uscode/text/21/384b'}, {'Title': '21', 'Section': '384c', 'headtext': ' Inspection of foreign food facilities', 'cleanpath': '/uscode/text/21/384c'}, {'Title': '21', 'Section': '384d', 'headtext': ' Accreditation of third-party auditors', 'cleanpath': '/uscode/text/21/384d'}, {'Title': '21', 'Section': '387', 'headtext': ' Definitions', 'cleanpath': '/uscode/text/21/387'}, {'Title': '21', 'Section': '387a', 'headtext': ' FDA authority over tobacco products', 'cleanpath': '/uscode/text/21/387a'}, {'Title': '21', 'Section': '387a-1', 'headtext': ' Final rule', 'cleanpath': '/uscode/text/21/387a-1'}, {'Title': '21', 'Section': '387b', 'headtext': ' Adulterated tobacco products', 'cleanpath': '/uscode/text/21/387b'}, {'Title': '21', 'Section': '387c', 'headtext': ' Misbranded tobacco products', 'cleanpath': '/uscode/text/21/387c'}, {'Title': '21', 'Section': '387d', 'headtext': ' Submission of health information to the Secretary', 'cleanpath': '/uscode/text/21/387d'}, {'Title': '21', 'Section': '387e', 'headtext': ' Annual registration', 'cleanpath': '/uscode/text/21/387e'}, {'Title': '21', 'Section': '387f', 'headtext': ' General provisions respecting control of tobacco products', 'cleanpath': '/uscode/text/21/387f'}, {'Title': '21', 'Section': '387f-1', 'headtext': ' Enforcement action plan for advertising and promotion restrictions', 'cleanpath': '/uscode/text/21/387f-1'}, {'Title': '21', 'Section': '387g', 'headtext': ' Tobacco product standards', 'cleanpath': '/uscode/text/21/387g'}, {'Title': '21', 'Section': '387h', 'headtext': ' Notification and other remedies', 'cleanpath': '/uscode/text/21/387h'}, {'Title': '21', 'Section': '387i', 'headtext': ' Records and reports on tobacco products', 'cleanpath': '/uscode/text/21/387i'}, {'Title': '21', 'Section': '387j', 'headtext': ' Application for review of certain tobacco products', 'cleanpath': '/uscode/text/21/387j'}, {'Title': '21', 'Section': '387k', 'headtext': ' Modified risk tobacco products', 'cleanpath': '/uscode/text/21/387k'}, {'Title': '21', 'Section': '387l', 'headtext': ' Judicial review', 'cleanpath': '/uscode/text/21/387l'}, {'Title': '21', 'Section': '387m', 'headtext': ' Equal treatment of retail outlets', 'cleanpath': '/uscode/text/21/387m'}, {'Title': '21', 'Section': '387n', 'headtext': ' Jurisdiction of and coordination with the Federal Trade Commission', 'cleanpath': '/uscode/text/21/387n'}, {'Title': '21', 'Section': '387o', 'headtext': ' Regulation requirement', 'cleanpath': '/uscode/text/21/387o'}, {'Title': '21', 'Section': '387p', 'headtext': ' Preservation of State and local authority', 'cleanpath': '/uscode/text/21/387p'}, {'Title': '21', 'Section': '387q', 'headtext': ' Tobacco Products Scientific Advisory Committee', 'cleanpath': '/uscode/text/21/387q'}, {'Title': '21', 'Section': '387r', 'headtext': ' Drug products used to treat tobacco dependence', 'cleanpath': '/uscode/text/21/387r'}, {'Title': '21', 'Section': '387s', 'headtext': ' User fees', 'cleanpath': '/uscode/text/21/387s'}, {'Title': '21', 'Section': '387t', 'headtext': ' Labeling, recordkeeping, records inspection', 'cleanpath': '/uscode/text/21/387t'}, {'Title': '21', 'Section': '387u', 'headtext': ' Studies of progress and effectiveness', 'cleanpath': '/uscode/text/21/387u'}, {'Title': '21', 'Section': '391', 'headtext': ' Separability clause', 'cleanpath': '/uscode/text/21/391'}, {'Title': '21', 'Section': '392', 'headtext': ' Exemption of meats and meat food products', 'cleanpath': '/uscode/text/21/392'}, {'Title': '21', 'Section': '393', 'headtext': ' Food and Drug Administration', 'cleanpath': '/uscode/text/21/393'}, {'Title': '21', 'Section': '393a', 'headtext': ' Office of Pediatric Therapeutics', 'cleanpath': '/uscode/text/21/393a'}, {'Title': '21', 'Section': '394', 'headtext': ' Scientific review groups', 'cleanpath': '/uscode/text/21/394'}, {'Title': '21', 'Section': '395', 'headtext': ' Loan repayment program', 'cleanpath': '/uscode/text/21/395'}, {'Title': '21', 'Section': '396', 'headtext': ' Practice of medicine', 'cleanpath': '/uscode/text/21/396'}, {'Title': '21', 'Section': '397', 'headtext': ' Contracts for expert review', 'cleanpath': '/uscode/text/21/397'}, {'Title': '5', 'Section': '552', 'headtext': ' Public information; agency rules, opinions, orders, records, and proceedings', 'cleanpath': '/uscode/text/5/552'}], 'Statutes at Large': [], 'Public Laws': [], 'Presidential Documents': []}